×
Industry Reports Services Press Release
  •   Blogs
  • Contact us About us

    North America Imaging Agents Market Forecast 2028 By Application (Oncology, Gastrointestinal, Cardiology Neurology), Product Type (Iodinated Contrast Media, Gadolinium-based Contrast Media, Microbubble Contrast Media, Barium-based Contrast Media), By Modality (X-Ray, Computed Tomography [CT], Magnetic Resonance Imaging [MRI], Ultrasound), By End-use (Hospitals, Ambulatory Surgical Centers, Diagnostic & Imaging Centers), Research Report, Country Outlook (U.S., Canada), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share
    Published Date: June 2022   |   Report ID: GR2142   |   Delivery: PDF  Request Free Sample

    Report Content

    Chapter 1   Methodology

    1.1    Definition and forecast parameters

    1.1.1    Definition

    1.1.2    Methodology and forecast parameters

    1.2    Data sources

    1.3    References & sources

    1.3.1    Secondary

    1.3.2    Primary

    Chapter 2   Executive Summary

    2.1    North America imaging agents industry summary, 2017 – 2028

    2.1.1    Business trends

    2.1.2    Product type trends

    2.1.3    Application trends

    2.1.4    Modality trends

    2.1.5    End-use trends

    2.1.6    Country trends

    Chapter 3   Industry Insights

    3.1    Industry segmentation

    3.2    Industry outlook, 2017 – 2028

    3.3    Major factor analysis

    3.3.1    Growth drivers

    3.3.1.1   Rapidly growing cancer and CVD population across the North America region

    3.3.1.2   Surging innovation in imaging procedures and agents

    3.3.1.3   Rising demand for image-guided procedures

    3.3.1.4   Increasing healthcare expenditure

    3.3.2    Restraints & challenges

    3.3.2.1   High costs of imaging agents and procedures

    3.3.2.2   Side effects associated with the imaging agents and diagnostic imaging procedures

    3.4    COVID-19 impact analysis

    3.5    Porter’s analysis

    3.6    Competitive review, 2021

    3.7    PEST analysis

    Chapter 4   North America Imaging Agents Market, By Product Type

    4.1    Key trends in North America imaging agents market, by product type

    4.2    Iodinated contrast media

    4.2.1    Market estimates and forecast, by country, 2017 -2028 (USD Million)

    4.3    Gadolinium-based contrast media

    4.3.1    Market estimates and forecast, by country, 2017 – 2028 (USD Million)

    4.4    Microbubble contrast media

    4.4.1    Market estimates and forecast, by country, 2017 – 2028 (USD Million)

    4.5    Barium-based contrast media

    4.5.1    Market estimates and forecast, by country, 2017 – 2028 (USD Million)

    Chapter 5   North America Imaging Agents Market, By Application

    5.1    Key trends in North America imaging agents market, by application

    5.2    Oncology

    5.2.1    Market estimates and forecast, by country, 2017 -2028 (USD Million)

    5.3    Cardiology

    5.3.1    Market estimates and forecast, by country, 2017 – 2028 (USD Million)

    5.4    Gastrointestinal

    5.4.1    Market estimates and forecast, by country, 2017 – 2028 (USD Million)

    5.5    Neurology

    5.5.1    Market estimates and forecast, by country, 2017 – 2028 (USD Million)

    5.6    Others

    5.6.1    Market estimates and forecast, by country, 2017 – 2028 (USD Million)

    Chapter 6   North America Imaging Agents Market, By Modality

    6.1    Key trends in North America imaging agents market, by modality

    6.2    X-Ray

    6.2.1    Market estimates and forecast, by country, 2017 -2028 (USD Million)

    6.3    Computed Tomography (CT)

    6.3.1    Market estimates and forecast, by country, 2017 – 2028 (USD Million)

    6.4    Magnetic Resonance Imaging (MRI)

    6.4.1    Market estimates and forecast, by country, 2017 – 2028 (USD Million)

    6.5    Ultrasound

    6.5.1    Market estimates and forecast, by country, 2017 – 2028 (USD Million)

    6.6    Others

    6.6.1    Market estimates and forecast, by country, 2017 – 2028 (USD Million)

    Chapter 7   North America Imaging Agents Market, By End-Use

    7.1    Key trends in North America imaging agents market, by end-use

    7.2    Hospitals

    7.2.1    Market estimates and forecast, by country, 2017 -2028 (USD Million)

    7.3    Ambulatory surgical centers

    7.3.1    Market estimates and forecast, by country, 2017 – 2028 (USD Million)

    7.4    Diagnostic & imaging centers

    7.4.1    Market estimates and forecast, by country, 2017 – 2028 (USD Million)

    7.5    Others

    7.5.1    Market estimates and forecast, by country, 2017 – 2028 (USD Million)

    Chapter 8   North America Imaging Agents market, By Country

    8.1    Key trends in North America imaging agents market, by country

    8.2    U.S.

    8.2.1    Market estimates and forecast, by product type, 2017 – 2028 (USD Million)

    8.2.2    Market estimates and forecast, by application, 2017 – 2028 (USD Million)

    8.2.3    Market estimates and forecast, by modality, 2017 – 2028 (USD Million)

    8.2.4    Market estimates and forecast, by end-use, 2017 – 2028 (USD Million)

    8.3    Canada

    8.3.1    Market estimates and forecast, by product type, 2017 – 2028 (USD Million)

    8.3.2    Market estimates and forecast, by application, 2017 – 2028 (USD Million)

    8.3.3    Market estimates and forecast, by modality, 2017 – 2028 (USD Million)

    8.3.4    Market estimates and forecast, by end-use, 2017 – 2028 (USD Million)

    Chapter 9   Company Profiles

    9.1    Aytu Biopharma

    9.1.1    Business overview

    9.1.2    Financial data

    9.1.3    Product landscape

    9.1.4    SWOT analysis

    9.2    Bayer Healthcare Pharmaceuticals

    9.2.1    Business overview

    9.2.2    Financial data

    9.2.3    Product landscape

    9.2.4    Strategic outlook

    9.2.5    SWOT analysis

    9.3    Bracco Diagnostics, Inc.

    9.3.1    Business overview

    9.3.2    Financial data

    9.3.3    Product landscape

    9.3.4    Strategic outlook

    9.3.5    SWOT analysis

    9.4    Curium Pharma

    9.4.1    Business overview

    9.4.2    Financial data

    9.4.3    Product landscape

    9.4.4    Strategic outlook

    9.4.5    SWOT analysis

    9.5    Eli Lilly & Company

    9.5.1    Business overview

    9.5.2    Financial data

    9.5.3    Product landscape

    9.5.4    Strategic outlook

    9.5.5    SWOT analysis

    9.6    GE Healthcare

    9.6.1    Business overview

    9.6.2    Financial data

    9.6.3    Product landscape

    9.6.4    Strategic outlook

    9.6.5    SWOT analysis

    9.7    Guerbet Group

    9.7.1    Business overview

    9.7.2    Financial data

    9.7.3    Product landscape

    9.7.4    Strategic outlook

    9.7.5    SWOT analysis

    9.8    Lantheus Medical Imaging, Inc.

    9.8.1    Business overview

    9.8.2    Financial data

    9.8.3    Product landscape

    9.8.4    Strategic outlook

    9.8.5    SWOT analysis

    9.9    Trivitron Healthcare

    9.9.1    Business overview

    9.9.2    Financial data

    9.9.3    Product landscape

    9.9.4    Strategic outlook

    9.9.5    SWOT analysis


    Get this research report on North America Imaging Agents Market customized according to your business requirements.

    report-purchase - logo Buy Now

    Why Choose us?

    • on-time delivery On-Time Delivery

      We commit to on-time delivery of reports to keep you ahead.

    • assured quality Assured Quility

      With a wide network of industry experts and trained in-house analysts, we assure best service quality.

    • Custom Research Service

      We offer research services to meet specific client requirements and provide them with actionable insights on target markets.

    • payment security Payment Security

      Our safe payment gateway gives you full control of your personal data, at all times.

    Connect with our sales team

      (+1)-208-273-9852

     [email protected]